Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-01-17 12:49 Tx date 2022-01-14 |
$IBH
Indigenous Bloom Hemp Corp. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+90,000 vol $0.11 each |
1,453,624 | |
Filed 2022-01-17 12:46 Tx date 2021-09-03 |
$IBH
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-276,907 vol |
276,906 | |
Filed 2021-09-24 15:29 Tx date 2021-09-03 |
$IBH
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-276,956 vol |
||
Filed 2021-09-24 16:49 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
||
Filed 2021-09-24 15:56 Tx date 2021-09-24 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,003,718 vol |
1,446,575 | |
Filed 2021-09-24 15:52 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
442,857 | |
Filed 2021-09-24 15:52 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
||
Filed 2021-09-24 15:29 Tx date 2021-09-03 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-276,956 vol |
276,857 | |
Filed 2021-09-15 20:22 Tx date 2021-09-15 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+3,000 vol $0.34 each |
61,400 | |
Filed 2021-09-15 20:22 Tx date 2021-09-14 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,422
+13,400 vol $0.33 each |
58,400 | |
Filed 2021-09-15 20:21 Tx date 2021-09-13 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+25,000 vol $0.26 each |
45,000 | |
Filed 2021-09-15 20:20 Tx date 2021-09-10 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+20,000 vol $0.25 each |
20,000 | |
Filed 2021-09-15 20:12 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-15 20:09 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,857
+83,000 vol $0.2031 each |
636,813 | |
Filed 2020-08-25 16:29 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
202,623 | ||
Filed 2020-08-25 16:28 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
553,813 |